| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Angiogenesis and metastasis
|
Ellis, L.M.
|
|
1996
|
32 |
14 |
p. 2451-2460
10 p.
|
artikel
|
| 2 |
Angiogenesis in primary lung cancer and lung secondaries
|
Pezzella, F.
|
|
1996
|
32 |
14 |
p. 2494-2500
7 p.
|
artikel
|
| 3 |
Angiogenesis research up to 1996. A commentary on the state of art and suggestions for future studies
|
Gasparini, G.
|
|
1996
|
32 |
14 |
p. 2379-2385
7 p.
|
artikel
|
| 4 |
Clinical significance of the determination of angiogenesis in human breast cancer: Update of the biological background and overview of the vicenza studies
|
Gasparini, G.
|
|
1996
|
32 |
14 |
p. 2485-2493
9 p.
|
artikel
|
| 5 |
Clinical significance of the determination of angiogenic factors
|
Toi, M.
|
|
1996
|
32 |
14 |
p. 2513-2519
7 p.
|
artikel
|
| 6 |
Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer
|
Talbot, B.C.
|
|
1996
|
32 |
14 |
p. 2528-2533
6 p.
|
artikel
|
| 7 |
How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases
|
Polverini, P.J.
|
|
1996
|
32 |
14 |
p. 2430-2437
8 p.
|
artikel
|
| 8 |
Intratumoral vascularity as a prognostic factor in cancers of the urogenital tract
|
Weidner, N.
|
|
1996
|
32 |
14 |
p. 2506-2512
7 p.
|
artikel
|
| 9 |
New perspectives in clinical oncology from angiogenesis research
|
Folkman, J.
|
|
1996
|
32 |
14 |
p. 2534-2539
6 p.
|
artikel
|
| 10 |
Prognostic value of angiogenesis in gastro-intestinal tumours
|
Chung, Y.S.
|
|
1996
|
32 |
14 |
p. 2501-2505
5 p.
|
artikel
|
| 11 |
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation
|
Vermeulen, P.B.
|
|
1996
|
32 |
14 |
p. 2474-2484
11 p.
|
artikel
|
| 12 |
Reciprocal paracrine interactions between tumour cells and endothelial cells: the ‘angiogenesis progression’ hypothesis
|
Rak, J.
|
|
1996
|
32 |
14 |
p. 2438-2450
13 p.
|
artikel
|
| 13 |
Role of integrins in angiogenesis
|
Brooks, P.C.
|
|
1996
|
32 |
14 |
p. 2423-2429
7 p.
|
artikel
|
| 14 |
Role of soluble mediators in angiogenesis
|
Bussolino, F.
|
|
1996
|
32 |
14 |
p. 2401-2412
12 p.
|
artikel
|
| 15 |
TNP-470 (AGM-1470): Mechanisms of action and early clinical development
|
Castronovo, V.
|
|
1996
|
32 |
14 |
p. 2520-2527
8 p.
|
artikel
|
| 16 |
TNP-470/minocycline/cytotoxic therapy: A systems approach to cancer therapy
|
Teicher, B.A.
|
|
1996
|
32 |
14 |
p. 2461-2466
6 p.
|
artikel
|
| 17 |
Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models
|
Hanahan, D.
|
|
1996
|
32 |
14 |
p. 2386-2393
8 p.
|
artikel
|
| 18 |
Tumour suppressor genes and angiogenesis: the role of TP53 in fibroblasts
|
Stellmach, V.
|
|
1996
|
32 |
14 |
p. 2394-2400
7 p.
|
artikel
|
| 19 |
Vascular endothelial growth factor
|
Ferrara, N.
|
|
1996
|
32 |
14 |
p. 2413-2422
10 p.
|
artikel
|
| 20 |
Vascular targeting of solid and ascites tumours with antibodies to vascular endothelial growth factor
|
Qu-hong, Ke-lin
|
|
1996
|
32 |
14 |
p. 2467-2473
7 p.
|
artikel
|
Tijdschrift beschrijving